Evercore ISI Reaffirms In-Line Rating for DENTSPLY SIRONA (NASDAQ:XRAY)

DENTSPLY SIRONA (NASDAQ:XRAY)‘s stock had its “in-line” rating reaffirmed by equities researchers at Evercore ISI in a report issued on Tuesday, Marketbeat.com reports. They presently have a $20.00 target price on the medical instruments supplier’s stock. Evercore ISI’s price objective would indicate a potential upside of 6.10% from the company’s current price.

Other equities analysts have also issued research reports about the stock. Robert W. Baird dropped their price objective on shares of DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating on the stock in a report on Friday, November 8th. StockNews.com cut DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Tuesday, November 19th. UBS Group cut their target price on DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating for the company in a research note on Tuesday, December 3rd. Mizuho started coverage on shares of DENTSPLY SIRONA in a report on Wednesday, December 4th. They issued a “neutral” rating and a $21.00 price target on the stock. Finally, Morgan Stanley cut their price objective on DENTSPLY SIRONA from $30.00 to $23.00 and set an “overweight” rating for the company in a report on Tuesday, December 17th. Nine investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to MarketBeat, DENTSPLY SIRONA currently has a consensus rating of “Hold” and a consensus target price of $27.27.

DENTSPLY SIRONA Stock Up 1.3 %

NASDAQ XRAY opened at $18.85 on Tuesday. DENTSPLY SIRONA has a fifty-two week low of $17.21 and a fifty-two week high of $37.60. The business has a fifty day moving average price of $19.45 and a two-hundred day moving average price of $23.21. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84. The stock has a market capitalization of $3.75 billion, a PE ratio of -9.11, a PEG ratio of 1.93 and a beta of 0.96.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 EPS for the quarter, beating the consensus estimate of $0.48 by $0.02. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The firm had revenue of $951.00 million during the quarter, compared to the consensus estimate of $939.10 million. During the same period last year, the company earned $0.49 earnings per share. The business’s quarterly revenue was up .4% on a year-over-year basis. Equities analysts expect that DENTSPLY SIRONA will post 1.84 earnings per share for the current fiscal year.

Institutional Investors Weigh In On DENTSPLY SIRONA

Institutional investors and hedge funds have recently bought and sold shares of the business. UMB Bank n.a. boosted its holdings in shares of DENTSPLY SIRONA by 430.3% during the 3rd quarter. UMB Bank n.a. now owns 928 shares of the medical instruments supplier’s stock valued at $25,000 after purchasing an additional 753 shares during the last quarter. Capital Performance Advisors LLP purchased a new stake in shares of DENTSPLY SIRONA in the third quarter worth approximately $27,000. Kennebec Savings Bank purchased a new stake in DENTSPLY SIRONA in the third quarter worth $35,000. Van ECK Associates Corp bought a new stake in DENTSPLY SIRONA during the 3rd quarter valued at about $42,000. Finally, Allworth Financial LP boosted its position in DENTSPLY SIRONA by 40.2% in the 3rd quarter. Allworth Financial LP now owns 2,179 shares of the medical instruments supplier’s stock valued at $59,000 after buying an additional 625 shares during the period. 95.70% of the stock is owned by institutional investors.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.